News Daily News HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI Yael L. Maxwell October 03, 2014
Presentation TCT 2014 Difficult Primary PCI Decisions Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab September 16, 2014
Presentation TCT 2014 BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention Presenter: Roxana Mehran, Harvey D. White, Yaling Han September 15, 2014
Presentation TCT 2014 The Data Strongly Support Bivalirudin! Presenter: Roxana Mehran September 14, 2014
News Daily News Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds Jason Kahn May 15, 2014
News Daily News BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients May 14, 2014
News Daily News HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes Yael L. Maxwell April 24, 2014
News Daily News HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis March 20, 2014
News Daily News HORIZONS-AMI: El Daño Renal Durante una PCI Primaria está Estrechamente asociado al Pronóstico March 20, 2014
News Daily News HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding Caitlin E. Cox November 01, 2013
Presentation TCT 2013 Current Choice of Antiplatelet Therapies in NSTEMI and STEMI Presenter: Roxana Mehran October 28, 2013
Presentation TCT 2013 Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter? Presenter: Roxana Mehran October 28, 2013
News Daily News Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina Caitlin E. Cox October 11, 2013
News Daily News High-Risk Subgroups Derive Kidney Protection from Rosuvastatin Caitlin E. Cox October 11, 2013
News Daily News HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients Leah Lawrence July 11, 2013